Business
Currency:JPY
2024/FY
Stock NameRevenueRatio
Pharmaceutical Business-Americas232.38B31.33%
Pharmaceutical Business-Japan216.94B29.25%
Pharmaceutical Business-People's Republic of China111.93B15.09%
Pharmaceutical Business-Europe, Middle East, Africa, Russia, Oceania (EMEA)75.99B10.24%
Pharmaceutical Business-Asia and Latin America54.23B7.31%
Other Business50.29B6.78%
View all
Region
Currency:JPY
2024/FY
Stock NameRevenueRatio
United States243.14B32.78%
Japan226.45B30.53%
People's Republic of China109.28B14.73%
Europe90.53B12.20%
Foreign countries61.74B8.32%
Americas10.61B1.43%
View all